Association between donor chimerism levels in various peripheral blood cell subpopulations and overall mortality and death or relapse/progression
. | Mortality . | . | . | Death or relapse/progression . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Subpopulation . | Hazard ratio* . | 95% Cl . | P . | Hazard ratio* . | 95% Cl . | P . | ||||
Granulocytes | 0.83 | 0.70-1.00 | .06 | 0.89 | 0.72-1.10 | .28 | ||||
T cells | 0.94 | 0.77-1.15 | .59 | 0.89 | 0.72-1.06 | .19 | ||||
Monocytes | 0.82 | 0.68-0.98 | .04 | 0.89 | 0.72-1.08 | .21 | ||||
NK cells | 0.83 | 0.68-1.02 | .09 | 0.79 | 0.64-0.96 | .02 |
. | Mortality . | . | . | Death or relapse/progression . | . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|
Subpopulation . | Hazard ratio* . | 95% Cl . | P . | Hazard ratio* . | 95% Cl . | P . | ||||
Granulocytes | 0.83 | 0.70-1.00 | .06 | 0.89 | 0.72-1.10 | .28 | ||||
T cells | 0.94 | 0.77-1.15 | .59 | 0.89 | 0.72-1.06 | .19 | ||||
Monocytes | 0.82 | 0.68-0.98 | .04 | 0.89 | 0.72-1.08 | .21 | ||||
NK cells | 0.83 | 0.68-1.02 | .09 | 0.79 | 0.64-0.96 | .02 |
Percent donor chimerism modeled as a continuous linear variable. Hazard ratio presented in terms of an increase in percent donor chimerism of 20%.